CANCER RESEARCH TRAINING AND EDUCATION COORDINATION (CRTEC) ? ABSTRACT Karmanos Cancer Institute (KCI) provides extensive cancer research training and educational programs that span all career stages. Dr. Michele Cote (PSDR), Associate Center Director for Education, leads KCI?s CRTEC efforts. In addition to identification, promotion, and support of University-sponsored training activities, Dr. Cote (PSDR) coordinates the cancer-specific programs at KCI. With the support of CRTEC Education Advisory Council members, each with expertise in a particular field or window of training, Dr. Cote (PSDR) serves as the main point of contact for trainees across the career trajectory. A key component of the CRTEC is to evaluate the effectiveness of the supported training activities, and identifying gaps and opportunities to enhance KCI training efforts across the spectrum. KCI?s education efforts span the education and training continuum including efforts focused on high school students, undergraduate students, graduate and medical students, post-doctoral trainees, residents and fellows, junior faculty, tenured faculty and community healthcare providers. CRTEC efforts are supported by ten active training projects totaling $895,210 direct costs. Several have grown out of a T32 led by Dr. Matherly (MT) (T32CA009531). This training program in the biology of cancer that has been continuously funded for over three decades. Since 2015, 24 students have been supported via the T32, five of whom were also awarded subsequent F30 or F31 support. Novel efforts at KCI include the launch of focuSStem in 2019, a program developed by a high school student, for high school students, with support from KCI leadership. In its inaugural year, five schools and 149 students have participated in the day-long program (37% African American, 30% non- Hispanic white, 27% Arab American, 4% Hispanic and 2% other races; over 50% females). A recent addition to our efforts in reaching high school students is the Discovery to Cure High School Internship Program (DTCHIP) (R25HD072591) led by Dr. Gil Mor (TBM) which will begin recruiting in the summer of 2020.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Wayne State University
United States
Zip Code
Li, Feng; Wang, Yongli; Li, Dapeng et al. (2018) Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov 13:643-660
Ramseyer, Vanesa D; Kimler, Victoria A; Granneman, James G (2018) Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Mol Metab 7:57-70
Healy, Mark A; Morris, Arden M; Abrahamse, Paul et al. (2018) The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer 18:481
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Alsaab, Hashem O; Sau, Samaresh; Alzhrani, Rami M et al. (2018) Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials 183:280-294
Chammaa, May; Malysa, Agnes; Redondo, Carlos et al. (2018) RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer. J Cell Physiol 233:9548-9562
Mills, Anne M; Peres, Lauren C; Meiss, Alice et al. (2018) Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES). Int J Gynecol Pathol :
Vaishampayan, Ulka N; Podgorski, Izabela; Heilbrun, Lance K et al. (2018) Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate Cancer. Clin Cancer Res :
Sexton, Rachel E; Hachem, Ali H; Assi, Ali A et al. (2018) Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer. Sci Rep 8:16008
Campbell, Douglas H; Lund, Maria E; Nocon, Aline L et al. (2018) Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer. PLoS One 13:e0196017

Showing the most recent 10 out of 826 publications